Showing posts with label infection. Show all posts
Showing posts with label infection. Show all posts

Friday, 6 November 2015

Has This Been Humanity's Deadliest Threat to Date?

Over the course of centuries, humans have witnessed the wrath of many deadly endemic, epidemic and pandemic diseases. Some notable examples include the uprising of small pox and the Bubonic plague. The number of deaths worldwide that have resulted are alarming. However, what is more profound is how fast the pathogens of these diseases spread in a population. In later years, the impact of these epidemics often become the subject of academic study in Medicine, in particular, epidemiology. In addition to these giants of infectious disease, there is another worth mentioning, which could be debated as 'the greatest medical holocaust in history' - the Spanish Flu of 1918.

Above: A Spanish flu ward at Fort Riley, Kansas, in 1918. (Source: The Guardian)

Caused by the H1N1 Influenza virus, the Spanish Flu was capable of rapid transmission, which resulted in it's success - 500 million people infected worldwide (one fifth of the world's population at that time (Source: Census.gov)). The fact that the infection numbers were indeed astronomically large, in the years post-pandemic, it was difficult to make an estimate of the mortality rate. Another reason is that many different countries around the world were affected by a preceding war, and different countries were affected to different extents. However, most sources indicate that the number of deaths ranged between 10-20% of those infected, i.e 50-100 million (Source: Archives.gov - The Deadly Virus). To put this into comparison, just over 17 million were killed over the duration of the Great War (Source: BBC). Despite the magnitude of destruction that the Spanish Flu inflicted, it has become a subject of lesser interest over the years. Looking back at these events, what could we learn to move ourselves forward in the medical field?


One of the great mysteries surrounding the Spanish Flu pandemic is that of the origin of the virus. Some of the latest media report that this virus is likely to have originated from the Far East, in particular, China. However, previous suggestions for the origin location range from Midwest America to France! It is generally accepted that the virus later mutated, causing the most destruction. According to the National Geographic, "new research is placing the flu's emergence in a forgotten episode of WW1: the shipment of Chinese labourers across Canada in sealed train cars." During the War, there was an increasing demand for labour, especially behind the British and French lines.


Above: Public notice for influenza in 1918 (Source: Wikipedia)


Unfortunately those that were infected often suffered unpleasant symptoms: bleeding from the nose and ears was common as well as (after autopsy) swollen hearts and lungs that had become solidified. Some figures showed that some lungs after autopsy measured up to six times their normal weight. The explanation for this is the build up of fluids (oedema) during the course of infection. This accumulation of fluid would have been a significant obstruction and gas exchange would have become increasingly difficult. It follows that as a result of this, many of those infected would die of asphyxiation. One of the physicians working at a military camp near Boston, Massachusetts in September 1918 describes the symptoms of asphyxiation one would typically have in vivid detail:

"Two hours after admission they have mahogany spots all over the cheek bones, and a few hours later you begin to see the cyanosis extending from their ears and spreading all over the face, until it is hard to distinguish the coloured men from the white. It is only a matter of a few hours then until death comes and is is a struggle for air until they suffocate. It is horrible. One can stand it to see one, two or twenty men, but to see these poor devils dropping like flies sort of gets on your nerves." 
                                                 
                                                                         - A physician stationed at Fort Devens, Boston, September 1918 (Source: Voices of the Pandemic) 

As well as these conditions that resulted from infection of the virus, often, many others would become ill from secondary infections such as pneumonia - a bacterial infection. The influenza virus is able to penetrate the respiratory system and damage the cilia and epithelial cells lining the lungs. The immunity of the infected is weakened due to the cells of the immune system losing their function. Thus, one becomes increasingly susceptible to pneumonia. 


(Above: Orginal photograph of the H1N1 virus, taken in the CDC Influenza Laboratory) 

As we know, the Spanish flu was caused by the H1N1 virus. What does this mean? Any virus that contain the letters H and N each followed by a number indicates that the virus is type A influenza. The letters H and N refer to haemagglutinin and neuraminidase respectively, the distinctive membrane proteins on the virus. Haemagglutinin binds to receptors on host cells. This causes fusion of the two membranes and deadly infiltration of the viral content. Neuraminidase acts at the end of the viral replication cycle - it 'cleaves' the new virus from the host cell. Now, the cycle is able to occur again and again, and other neighbouring cells become infected. Moreover, the proteins can actually prove very useful - they are extracted from circulating strains, purified, and use in a flu jab vaccine that is given every year.

However, what made H1N1 in 1918 such a big problem was the concept of genetic drift. This became apparent in 2005, when a group of American scientists sequenced the genome of the 1918 flu virus. The tissue sample came from a female patient who was buried in an Alaskan permafrost. The shift was gradual, initially being carried in an avian host. The H1N1 was able to mutate during the course of the pandemic, making it's infection very potent. A mutation in the genome would have caused the subsequent virus to produce subtly different variations of haemagglutinin and neuraminidase. As a consequence, antibodies produced by the host will no longer be able to bind to these proteins. The virus evades the immune response.



Above: The pathogenesis of an influenza A type virus (Source: Biological Sciences Review Volume 27, Number 4)


You might argue that perhaps only the most vulnerable would have been at risk. However the virus was evidently very potent and not discriminatory it would seem. The flu was prevalent in rural as well as urban areas - even the most remote parts of Alaska were affected! Usually, young adults tend to be the least affected when it comes these types of infectious diseases - their immune systems are generally well developed. However, for the Spanish flu, it was the exact opposite. This group tended to be severely affected, along with the vulnerable groups (elderly and young children). One astonishing statistic is that the average life expectancy of the USA dropped by twelve years during one year of the pandemic alone. (Source: Archives.gov)

Above: Age profile of deaths from Spanish flu (Source: Data from Centers for Disease Control and Prevention)

In the graph above, we can compare the deaths for each age group during the period 1911-1917 to the year 1918 - the year of the Spanish flu. What is unusual is the spike in deaths in the age group for young adults. Over the years, this has intrigued epidemiologists - however one theory that does exist to explain this oddity of flu epidemics is the 'cytokine storm'. This relates to the idea that the young and healthy have the most powerful and effective immune systems. However, during an infection with flu, the immune response can too excessive, becoming detrimental to health. Cytokines are chemical released by cells of the immune system during an infection to provide a means of cell communication. Some cytokines accelerate chemical processes, whilst others inhibit them. They also cause increased inflammation, swelling, and vasopermiability (the blood vessels become more permeable). Usually, this would help to fight the infection, however sometimes this response can come at the expense of an organ that has an oedema (and reduced blood supply). A consequence of this is tissue scarring, and then multiple organ failure. So, in the case of Spanish flu, an 'overreaction' of the immune system can indeed prove fatal (Source: Biological Sciences Review Volume 27, Number 4).


What could be done in the future? According to the World Health Organisation, the next pandemic 'will kill between 2 and 7.4 million people'. H5N1 (bird flu) is considered the most dangerous currently. In future, epidemiologists will need to keep watch for emerging epidemics that could potentially become catastrophic pandemics. In the field of infectious diseases, emphasis is being placed on prevention, more than ever before.

In addition to the reference provided above, credit should be given to Bethany Butcher who wrote an article on Spanish flu for the Biological Sciences Review April issue, 2015.
Extra reading:


Sunday, 15 February 2015

Hepatitis C - Can We Use Genetics To Find Effective Treatments?

As devastating as viral infections go, Hepatitis C is one of the most severe, in worst cases leading to cirrhosis - liver tissue scarring. There have been cases where individuals have developed cancer as a result of the destruction due to the Hepatitis C virus. The success of the Hepatitis C virus is largely due to the survival of its most deadliest strains. The fact that humans are the only species as far as we know that can be infected with HCV makes us somewhat more vulnerable. What is more interesting is that despite all our current knowledge on viral replication and adaptation, the mechanism of this virus infiltrating cells and causing damage is not fully understood. You could argue this 'void' in our scientific knowledge is preventing us from devising effective treatments, not only to this particular type of infection, but others too. However just like any other virus strain, the Hepatitis C strain which causes disease does utilise the host cells 'machinery' in order to replicate itself multiple times. It follows that whole new virions are produced from the newly synthesised viral protein. Despite there being some individuals who are able to fight off the virus, most people develop a chronic infection which can last as long as a lifetime. Continued degrading of the liver over a prolonged period means that eventually the liver cells lose function -  only a liver transplant can save the life of the patient.

What seems reassuring statistically, is that according to the World Health Organisation, around 3% of people worldwide are affected severely by the Hepatitis C virus (HCV). A small percentage one may consider, however it equates to a very large quantity. Additionally, a large number of people may have not been diagnosed with the infection as the infection takes time to develop. This can only mean that the actual number of people affected chronically with HCV is much higher.

A Summary of HCV Transmission:

A blood-bourne infection, HCV is commonly transmitted through (vascular) medical operations, or through intravenous drug usage. There have been nationwide catastrophes in some countries where blood, contaminated by HCV, has been used for transfusions. The identification of the virus was too late, and many people were medically affected.

The origin of the spread of HCV is largely unknown, although many agree that it could have been initially spread by some kind of vector, a mosquito being a predictable example. It has been discovered that the virus can spread through sexual transmission, however blood-to-blood contact is seen as the most efficient method of the virus' transmission.

Above: Electron Micrograph of the Hepatits C Virus (HCV) isolated from cell culture (Wikipedia)


The Significance of the Viral Genome:

The HCV, as characteristic of many viruses, is able to mutate at a frequent rate, making it very difficult to develop a long-lasting vaccine. The length of its genome is relatively short at around 10000 nucleotides long. The primary reason for the rapid mutating of the HCV genome, is that unlike in humans, the HCV virus has no mechanisms in place to proof-read its own DNA. This frequency results in copying errors during the process of DNA replication. Combining this feature (or rather a lack of it), with HCV's ability to replicate at an extraordinary rate, results in many mutations in the viral DNA sequence.

To most people, a mutation is seen an event detrimental to the host organisms, however this isn't always the case. In viruses, due to the large number of mutations that occur, mutations can sometimes be advantageous. Therefore the virus is able to acquire a protein that serves valuable to virus, allowing it to survive in more extreme conditions. One application of this is that an advantageous mutation can cause a virus to the evade the host organism's immune response. The host's own cells may recognise the new viral proteins as 'self' and thus fail to identify the intruder.

As mentioned, the HCV constitutes many different strains, and there is scientific evidence of this. Comparing HCV genomes from around the world, where it has caused infection in the local population, has given scientists insight into the impressive genetic diversity of this virus. Such diversity is simply uncharacteristic of most organisms, take humans as an example: 'the difference between the DNA sequences of individual humans is less than 1%'. However no matter how genetically diverse the HCV is, liver disease still developed upon infection.

Scientists have managed to categorise the differences between HCV strains, and classify the different HCV genotypes. The seven major genotypes of HCV range from G1 to G7. Each strain is prominent in different areas of the globe:

  • G1 - found in Africa (endemic - constant transmission rates) as well as parts of Europe, the USA and Japan (causes epidemics - greatly fluctuating transmission rates).
  • G2 - found in  Western Africa (endemic) and near Mexico
  • G3 - found in Asia (endemic) - in and around Northern India
  • G4 - found in (Central) Africa (endemic) 
  • G5 - found in (southern) Africa (endemic)
  • G6 - found in (Eastern) Asia (endemic)
  • G7 - found in (Central) Africa
Above: World map showing the distribution of various strains of HCV and relative proportions of different genome types in each area (Hepatitis C Education & Prevention Society)


What is intriguing is that worldwide medical data suggests that some strains of HCV are statistically easier to treat than others. Take G1 and G2 as examples. G1 is in fact the most common type of HCV in the UK and is notoriously difficult to eradicate, 'only 50% of G1-infected people are treated successfully'. However G2 induced Hepatitis seems easier to treat, with success rates as high as 80%.

Looking to the Future:

Recent developments in genome sequencing, drug synthesis and virology has enabled scientists to develop potential drugs to combat this deadly virus. In today's world however the HCV isn't the only significant threat to global health, with HIV/AIDS being a notable contender. The primary function of these new drugs is to inhibit particular stages of the viral life cycle, by targeting viral enzymes. This is a more virus-directed approach which contrasts greatly to old drugs, which only focused on increasing the strength and effectiveness of the host's immune system. Additionally, knowing the differences in the genotype between strains of HCV will enable scientists to develop drugs capable of destroying all strains in equal effectiveness.

So who will win this 'evolutionary arms race'?

References:

Credit to Dr Rebecca Gray PhD, who is studying the evolution of HCV and is now a research fellow at the University of Oxford for her original article on Hepatitis C published in the Biological Sciences Review (Volume 26, Number 1).

Additional credit - 'Hepatitis C - NHS Choices'. Read more.
(Image references are given in captions)

Further reading:
 - The World Health Organisation provides more information on the Hepatitis C Virus. Read more